Clinical Trial Update: Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of the new treatment degarelix for prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-03-31